Related Experiment Video
Updated: Dec 18, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
Pediatric cancer research: Surviving COVID-19
Jeffery J Auletta1,2,3,4, Peter C Adamson5, Jonathan E Agin6
1Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio.
Pediatric Blood & Cancer
|June 20, 2020
Summary
Pediatric cancer research faces challenges due to coronavirus disease 2019 (COVID-19). Experts discuss translational research, COVID-19
Area of Science:
- Pediatric oncology
- Translational research
- Infectious disease epidemiology
Background:
- The coronavirus disease 2019 (COVID-19) pandemic has presented unprecedented challenges to global health.
- Pediatric cancer research, crucial for improving outcomes in young patients, has been significantly impacted.
- A multidisciplinary panel convened to address these impacts and outline future directions.
Purpose of the Study:
- To analyze the impact of COVID-19 on pediatric cancer research.
- To identify key areas where COVID-19 research can inform pediatric oncology.
- To propose strategies for sustaining and advancing pediatric cancer research during and post-pandemic.
Main Methods:
- Expert consensus and discussion among a diverse panel.
- Review of the role of translational research in pediatric cancer.
- Analysis of COVID-19's effects on research infrastructure and progress.
Main Results:
- Translational research is vital for pediatric cancer breakthroughs.
- COVID-19 has disrupted clinical trials, funding, and collaboration in pediatric oncology.
- COVID-19 research offers potential insights into immunity, oncogenesis, and novel therapeutics applicable to pediatric cancers.
Conclusions:
- Sustained focus on pediatric cancer research is essential despite pandemic-related challenges.
- Leveraging insights from COVID-19 research can accelerate progress in pediatric oncology.
- Strategic planning is required to ensure the continuity and advancement of pediatric cancer research globally.
Related Concept Videos
01:21Cancer Survival Analysis
573
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
573
01:03Rous Sarcoma Virus (RSV) and Cancer
6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.0K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
02:18Cancer
53.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.2K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
182
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
182